PDL Biopharma
PDLI
#8394
Rank
โ‚น26.14 B
Marketcap
โ‚น228.87
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -โ‚น9.63 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are โ‚น80.61 Million. In 2019 the company made an earning of -โ‚น5.78 Billion a decrease over its 2018 earnings that were of -โ‚น4.06 Billion.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-โ‚น9.63 Billion66.55%
2019-โ‚น5.78 Billion42.43%
2018-โ‚น4.06 Billion-121.38%
2017โ‚น18.97 B60.41%
2016โ‚น11.82 B-77.09%
2015โ‚น51.62 B3.09%
2014โ‚น50.08 B26.65%
2013โ‚น39.54 B19.82%
2012โ‚น33.00 B3.68%
2011โ‚น31.83 B77.17%
2010โ‚น17.96 B-35.29%
2009โ‚น27.76 B23.45%
2008โ‚น22.49 B-1751.42%
2007-โ‚น1.37 Billion-88.56%
2006-โ‚น11.91 Billion93.73%
2005-โ‚น6.15 Billion13.63%
2004-โ‚น5.41 Billion32.12%
2003-โ‚น4.1 Billion87.44%
2002-โ‚น2.19 Billion-302.45%
2001โ‚น1.07 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚น3.221 T-26,529.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1.024 T-8,501.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น10.23 Billion-16.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น3.23 B-126.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
-โ‚น14.19 Billion 16.39%๐Ÿ‡บ๐Ÿ‡ธ USA